Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Children's Oncology Group
Children's Hospital of Philadelphia
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Johns Hopkins All Children's Hospital
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Florida
Assistance Publique - Hôpitaux de Paris
City of Hope Medical Center
Ann & Robert H Lurie Children's Hospital of Chicago
Therapeutic Advances in Childhood Leukemia Consortium
University Health Network, Toronto
Columbia University
Masonic Cancer Center, University of Minnesota
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Children's Oncology Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Columbia University
Great Ormond Street Hospital for Children NHS Foundation Trust
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Children's Oncology Group
Celgene
University College, London
Case Comprehensive Cancer Center
Children's Oncology Group
Vanderbilt-Ingram Cancer Center
Children's Oncology Group
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
OHSU Knight Cancer Institute